Enabling digital capabilities in a highly regulated environment for building Pharma 4.0

About the session

Digitalisation has enabled greater opportunities for innovation throughout the life-cycle of pharmaceutical products. There's a greater degree of connectivity and transparency, which has now imposed a closer and greater control over operations and quality, allowing faster decision-making. However, on the contrary, upgrading to Pharma 4.0 demands higher levels of security, owing to the increased vulnerability of interconnected automated systems.

See More See Less
Up Next
Up Next
Suggested stories from YourStory TV

Hybrid work culture leveraging modern technology
00:11:54

Dr D Y Patil Pratishthan's digital transformation
00:06:05

The post-pandemic era: Peter Jayaseelan on reinventing how we work
00:27:59

Scaling in the new normal with flexible work solutions
00:59:07

Empowering the global education dream with LeapScholar
00:25:23

Pfizer INDovation Program: Revolutionising the next frontier in Digital Health and Oncology
00:04:26